Fairvalue-Calculator Fairvalue-Calculator
EN DE

International Biotechnology Trust plc (IBT) Fair Value & Analysis

Healthcare · GB · Market cap 312M GBX

Pricep10.60
Fair Valuep21.20
Upside+100.0%
Quality95/100
Evidence: Medium Range p11.43 – p36.89

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

International Biotechnology Trust plc (IBT) currently trades at p10.60, while our model-based Fair Value estimate is p21.20 — implying the stock looks roughly 100.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology fo…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is International Biotechnology Trust plc (IBT) undervalued?
As of Jun 26, 2026, our model estimates a fair value of p21.20 versus a price of p10.60 — about +100% (undervalued). Model-based estimate, not financial advice.
What is the fair value of IBT?
Our 21-model fair value for International Biotechnology Trust plc is p21.20 (as of Jun 26, 2026), built from audited fundamentals. The current price is p10.60.
What is the quality score of IBT?
International Biotechnology Trust plc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.